Qi Zhou

4.1k total citations
99 papers, 2.2k citations indexed

About

Qi Zhou is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Qi Zhou has authored 99 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 29 papers in Molecular Biology and 19 papers in Cancer Research. Recurrent topics in Qi Zhou's work include Cancer Immunotherapy and Biomarkers (18 papers), RNA modifications and cancer (10 papers) and Ovarian cancer diagnosis and treatment (9 papers). Qi Zhou is often cited by papers focused on Cancer Immunotherapy and Biomarkers (18 papers), RNA modifications and cancer (10 papers) and Ovarian cancer diagnosis and treatment (9 papers). Qi Zhou collaborates with scholars based in China, United States and United Kingdom. Qi Zhou's co-authors include Jingting Jiang, Xiao Zheng, Kathleen F. Pirollo, Esther H. Chang, Antonina Rait, Gerald Zon, Richard I. Hogrefe, Lujun Chen, Changping Wu and Changping Wu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Qi Zhou

93 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi Zhou China 26 938 872 518 438 317 99 2.2k
Huaxiang Xu China 23 735 0.8× 1.0k 1.1× 477 0.9× 662 1.5× 173 0.5× 54 2.1k
Laurence Panicot‐Dubois France 27 895 1.0× 816 0.9× 357 0.7× 633 1.4× 297 0.9× 70 2.7k
Min Luo China 26 1.0k 1.1× 606 0.7× 449 0.9× 449 1.0× 247 0.8× 116 2.3k
Eduard Ryschich Germany 26 884 0.9× 1.2k 1.4× 489 0.9× 803 1.8× 424 1.3× 73 2.6k
Lan Coffman United States 21 844 0.9× 811 0.9× 450 0.9× 449 1.0× 157 0.5× 48 2.8k
Mauricio Cuello Chile 25 984 1.0× 823 0.9× 527 1.0× 275 0.6× 478 1.5× 72 2.4k
Walter E. Aulitzky Germany 34 1.4k 1.5× 1.1k 1.2× 385 0.7× 502 1.1× 270 0.9× 121 3.6k
Pierosandro Tagliaferri Italy 34 1.1k 1.2× 1.7k 1.9× 615 1.2× 645 1.5× 267 0.8× 97 3.2k
Beihua Kong China 32 1.2k 1.3× 611 0.7× 685 1.3× 487 1.1× 311 1.0× 121 3.1k
Frank Gieseler Germany 28 1.1k 1.1× 1.3k 1.5× 516 1.0× 387 0.9× 203 0.6× 97 2.6k

Countries citing papers authored by Qi Zhou

Since Specialization
Citations

This map shows the geographic impact of Qi Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Zhou more than expected).

Fields of papers citing papers by Qi Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Zhou. The network helps show where Qi Zhou may publish in the future.

Co-authorship network of co-authors of Qi Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Zhou. A scholar is included among the top collaborators of Qi Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Zhou. Qi Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Xingfeng, Jiale Qin, Xiang Zhang, et al.. (2025). Single-cell and spatial-resolved profiling reveals cancer-associated fibroblast heterogeneity in colorectal cancer metabolic subtypes. Journal of Translational Medicine. 23(1). 175–175. 8 indexed citations
2.
Li, Xiaofeng, Yang Wang, Qiang Hu, et al.. (2025). Screening and identification of versican as a sensitive biomarker and potential therapeutic target in basal cell carcinoma. International Journal of Medical Sciences. 22(10). 2488–2501. 1 indexed citations
3.
4.
Yuan, Yi‐Wu, et al.. (2024). The Role of Methionine Restriction in Gastric Cancer: A Summary of Mechanisms and a Discussion on Tumor Heterogeneity. Biomolecules. 14(2). 161–161. 2 indexed citations
5.
Zhou, Qi, Zijian Li, & Yaming Xi. (2024). EV-mediated intercellular communication in acute myeloid leukemia: Transport of genetic materials in the bone marrow microenvironment. Experimental Hematology. 133. 104175–104175. 1 indexed citations
6.
7.
Wang, Wei, et al.. (2024). Sema3A Affect Osteolytic Bone Metastasis of Non-small Cell Lung Cancer. Recent Patents on Anti-Cancer Drug Discovery. 20(4). 589–600. 1 indexed citations
8.
Zhou, Qi, Gang Chen, Yuanming Shen, et al.. (2023). Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103). Journal of Gynecologic Oncology. 34(3). e55–e55. 3 indexed citations
9.
Luo, Yong, et al.. (2023). Visually controlled pulsatile release of insulin from chitosan poly-acrylic acid nanobubbles triggered by focused ultrasound. International Journal of Pharmaceutics. 643. 123266–123266. 6 indexed citations
10.
Hong, Liangli, Qi Zhou, Ke Cheng, et al.. (2023). CD22 is a potential target of CAR-NK cell therapy for esophageal squamous cell carcinoma. Journal of Translational Medicine. 21(1). 710–710. 10 indexed citations
11.
Feng, Jifeng, Jing Wang, Qi Zhou, et al.. (2022). SHR-1701, a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, for Recurrent or Metastatic Cervical Cancer: A Clinical Expansion Cohort of a Phase I Study. Clinical Cancer Research. 28(24). 5297–5305. 42 indexed citations
12.
Hu, Can, Jiale Sun, Zhiyu Zhang, et al.. (2022). Development and external validation of a novel nomogram to predict prostate cancer in biopsy‐naïve patients with PSA <10 ng/ml and PI‐RADS v2.1 = 3 lesions. Cancer Medicine. 12(3). 2560–2571. 10 indexed citations
13.
Hu, Shangying, Xuelian Zhao, Fanghui Zhao, et al.. (2022). Implementation of visual inspection with acetic acid and Lugol's iodine for cervical cancer screening in rural China. International Journal of Gynecology & Obstetrics. 160(2). 571–578. 5 indexed citations
14.
Xia, Lingfang, Qi Zhou, Yunong Gao, et al.. (2022). A multicenter phase 2 trial of camrelizumab plus famitinib for women with recurrent or metastatic cervical squamous cell carcinoma. Nature Communications. 13(1). 7581–7581. 17 indexed citations
15.
Zhou, Liqiang, Hao Lü, Fei Zeng, et al.. (2021). Constructing a new prognostic signature of gastric cancer based on multiple data sets. Bioengineered. 12(1). 2820–2835. 21 indexed citations
16.
Zhou, Qi, Yuan Li, Lujun Chen, et al.. (2021). Long Non-Coding RNA GRIK1-AS1 Inhibits the Proliferation and Invasion of Gastric Cancer Cells by Regulating the miR-375/IFIT2 Axis. Frontiers in Oncology. 11. 754834–754834. 4 indexed citations
17.
Guo, Yiwen, Shanzhou� Huang, Wenting Zhao, et al.. (2021). DTYMK Expression Predicts Prognosis and Chemotherapeutic Response and Correlates with Immune Infiltration in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 8. 871–885. 14 indexed citations
18.
Li, Jing, Lujun Chen, Xiao Zheng, et al.. (2017). Knockdown of PD-L1 in Human Gastric Cancer Cells Inhibits Tumor Progression and Improves the Cytotoxic Sensitivity to CIK Therapy. Cellular Physiology and Biochemistry. 41(3). 907–920. 81 indexed citations
19.
20.
Yi, Yuexiong, et al.. (2011). Meta-analysis: the comparison of clinical results between vaginal and laparoscopic myomectomy. Archives of Gynecology and Obstetrics. 283(6). 1275–1289. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huaxiang Xu Breakdown of academic impact, for papers by Laurence Panicot‐Dubois Breakdown of academic impact, for papers by Min Luo Breakdown of academic impact, for papers by Eduard Ryschich Breakdown of academic impact, for papers by Lan Coffman Breakdown of academic impact, for papers by Mauricio Cuello Breakdown of academic impact, for papers by Walter E. Aulitzky Breakdown of academic impact, for papers by Pierosandro Tagliaferri Breakdown of academic impact, for papers by Beihua Kong Breakdown of academic impact, for papers by Frank Gieseler
Rankless by CCL
2026